Article
New druggable targets in the Ras pathway?
Current opinion in molecular therapeutics - 1 Dec 2010
Matallanas David, Crespo Piero
Abstract excerpt
Ras proteins are key elements in the regulation of cellular proliferation, differentiation and survival. Mutational activation of Ras or of components of its effector pathways are detected in one-third of human cancers and are essential for the genesis and maintenance of the tumoral phenotype. Research efforts have been dedicated to the development of therapeutic agents that inhibit aberrant Ras signals and,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
